Tokyo, (March 29, 2023) — Evident Corporation ("Evident") announces that the closing date of the transfer of all shares of Evident, a specified subsidiary of Olympus, to K.K. BCJ-66, a special purpose company indirectly owned by funds advised by Bain Capital Private Equity, LP (together with its affiliates, “Bain Capital”) has been scheduled for April 3, 2023.

Reasons for postponement of the closing of the transfer

The transfer is subject to certain conditions including obtainment of approvals from relevant authorities pursuant to the competition laws and related laws and regulations of Japan and other relevant jurisdictions. Due to the expectation that additional time is needed to obtain such approvals in certain countries, the closing date of the transfer has been postponed.

Since Olympus and Bain Capital have completed all the necessary procedures for the transfer, it is decided that the closing date of the transfer to be changed from March 2023 (scheduled) to April 3, 2023.

Link to the Olympus announcement.

About EVIDENT

For over 100 years as Olympus, we set the industry standard for optical precision in microscopy, helping the world see what was once out of view. Today, as Evident, we continue to help scientists, physicians, and engineers illuminate the unseen with advanced imaging solutions that combine renowned optics with cutting-edge digital innovation.

Our life science portfolio supports research, clinical diagnostics, and education, offering a comprehensive range of imaging methods from essential brightfield and darkfield microscopy to advanced fluorescence, 4D analysis, and digital pathology. In industrial microscopy, we deliver precision and flexibility through laser scanning, digital, and semiconductor microscopes designed for tasks ranging from routine inspection to intricate quality control and manufacturing analysis.

Whether advancing new therapies, ensuring product integrity, or exploring the unknown, Evident is defining a new era of discovery with easy-to-use tools that help unlock hidden answers and empower exciting new breakthroughs.

Evident is headquartered in Tokyo and supported by R&D and manufacturing centers in Japan, the United States, Germany, and China, with operations and dedicated sales and service centers around the world. For more information, visit EvidentScientific.com.